His primary scientific interests are in Prostate cancer, Surgery, Internal medicine, Prostate and Urology. His studies deal with areas such as Cancer research and Biopsy as well as Prostate cancer. Georg Bartsch focuses mostly in the field of Surgery, narrowing it down to matters related to Kidney disease and, in some cases, Kidney.
His Internal medicine study frequently involves adjacent topics like Endocrinology. His Prostate research integrates issues from Immunohistochemistry, Stromal cell, Hyperplasia and Pathology. His Prostate-specific antigen research includes elements of Prostatectomy and Gynecology.
His primary areas of investigation include Internal medicine, Prostate cancer, Surgery, Urology and Prostate. His research in Internal medicine intersects with topics in Endocrinology and Oncology. His biological study spans a wide range of topics, including Cancer research and Biopsy.
In his study, which falls under the umbrella issue of Urology, Urinary bladder is strongly linked to Urinary system. His Prostate research is multidisciplinary, relying on both Stromal cell, Hyperplasia, Pathology and Radiology. While the research belongs to areas of Androgen, he spends his time largely on the problem of Androgen receptor, intersecting his research to questions surrounding Receptor.
His scientific interests lie mostly in Internal medicine, Prostate cancer, Urology, Surgery and Oncology. Georg Bartsch has included themes like Endocrinology and Radiology in his Internal medicine study. His Prostate cancer research incorporates themes from Prostate and Gynecology.
His Prostate study frequently draws connections to adjacent fields such as Biopsy. Georg Bartsch combines subjects such as Prostatectomy, Urinary system and Pathology with his study of Urology. The study incorporates disciplines such as Cystectomy, Nephrectomy and Rhabdosphincter in addition to Surgery.
His primary areas of study are Prostate cancer, Cancer, Urology, Prostate and Surgery. Georg Bartsch interconnects Biopsy and Cancer research in the investigation of issues within Prostate cancer. His research integrates issues of Hemodynamics and Urinary system in his study of Urology.
The concepts of his Prostate study are interwoven with issues in Biomarker, Epithelium, Stromal cell and Analytical chemistry. His Surgery study combines topics from a wide range of disciplines, such as Rhabdosphincter and Internal medicine. His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
Zoran Culig;Alfred Hobisch;Marcus V. Cronauer;Christian Radmayr.
Cancer Research (1994)
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
Z. Culig;A. Hobisch;M. V. Cronauer;A. C. B. Cato.
Molecular Endocrinology (1993)
Robotic-assisted laparoscopic partial nephrectomy: Technique and initial clinical experience with daVinci robotic system
Matthew T. Gettman;Michael L. Blute;George K. Chow;Richard Neururer.
Interleukin-6 Regulates Prostate-specific Protein Expression in Prostate Carcinoma Cells by Activation of the Androgen Receptor
Alfred Hobisch;Iris E. Eder;Thomas Putz;Wolfgang Horninger.
Cancer Research (1998)
Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells.
Lorenz Höltl;Claudia Zelle-Rieser;Hubert Gander;Christine Papesh.
Clinical Cancer Research (2002)
Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: The prospective european doxazosin and combination therapy (predict) trial
Roger S Kirby;Claus Roehrborn;Peter Boyle;Georg Bartsch.
Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
Z Culig;J Hoffmann;M Erdel;I E Eder.
British Journal of Cancer (1999)
Evaluation and management of renal injuries: consensus statement of the renal trauma subcommittee.
R A Santucci;H Wessells;G Bartsch;J Descotes.
Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria.
Georg Bartsch;Wolfgang Horninger;Helmut Klocker;Andreas Reissigl.
Testicular Torsion: Late Results with Special Regard to Fertility and Endocrine Function
G. Bartsch;St. Frank;H. Marberger;G. Mikuz.
The Journal of Urology (1980)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: